Ascelia Pharma AB (publ) (ACE) — Financial Flexibility Index
Ascelia Pharma AB (publ) (ACE) has a Financial Flexibility Index of -0.71x as of September 2025. Free cash flow of Skr-15.60 Million (operating CF Skr-15.66 Million minus capex Skr57.00K) represents -1% of total liabilities (Skr22.01 Million). Check ACE strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascelia Pharma AB (publ) Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Ascelia Pharma AB (publ) across 8 annual periods. See ACE working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ascelia Pharma AB (publ) (2017–2024)
Year-by-year free cash flow to debt coverage for Ascelia Pharma AB (publ). For the full company profile including market capitalisation, see Ascelia Pharma AB (publ) (ACE) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | Skr-62.84 Million | Skr-62.84 Million | Skr61.98 Million | — |
| 2023 | 0.00x | Skr0.00 | Skr-126.79 Million | Skr12.74 Million | ▲ +100.0% |
| 2022 | -3.32x | Skr-125.20 Million | Skr-125.26 Million | Skr37.71 Million | ▲ +26.9% |
| 2021 | -4.54x | Skr-116.52 Million | Skr-116.56 Million | Skr25.66 Million | ▼ -3.0% |
| 2020 | -4.41x | Skr-85.13 Million | Skr-85.53 Million | Skr19.32 Million | ▼ -58.8% |
| 2019 | -2.77x | Skr-36.52 Million | Skr-36.92 Million | Skr13.16 Million | ▼ -5.1% |
| 2018 | -2.64x | Skr-29.94 Million | Skr-30.33 Million | Skr11.35 Million | ▲ +43.3% |
| 2017 | -4.65x | Skr-20.56 Million | Skr-20.96 Million | Skr4.42 Million | — |